AXSM - Axsome Therapeutics, Inc.
161.46
-2.620 -1.623%
Share volume: 494,537
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$164.08
-2.62
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-06-2024 | 08-05-2024 | 11-12-2024 | 02-18-2025 | 05-05-2025 | 08-04-2025 | 11-03-2025 | 02-23-2026 | |
| Assets | |||||||||
| Total Assets | 545.728 M | 548.226 M | 561.458 M | 568.498 M | 596.671 M | 639.785 M | 669.250 M | 689.805 M | |
| Current Assets | 460.490 M | 463.027 M | 479.113 M | 485.064 M | 494.634 M | 536.620 M | 565.342 M | 588.986 M | |
| Inventories | 15.583 M | 15.220 M | 14.265 M | 15.732 M | 16.319 M | 18.441 M | 23.774 M | 27.938 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 331.441 M | 315.657 M | 327.341 M | 315.353 M | 300.910 M | 303.016 M | 325.272 M | 322.933 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 812.000 K | 724.000 K | 683.000 K | 584.000 K | 773.000 K | 667.000 K | 605.000 K | 562.000 K | |
| Other Assets | 84.426 M | 84.475 M | 81.662 M | 82.850 M | 101.264 M | 102.498 M | 103.303 M | 100.257 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 545.728 M | 548.226 M | 561.458 M | 568.498 M | 596.671 M | 639.785 M | 669.250 M | 689.805 M | |
| Total liabilities | 401.692 M | 445.374 M | 468.560 M | 511.483 M | 543.466 M | 566.710 M | 595.523 M | 601.510 M | |
| Total current liabilities | 144.048 M | 186.570 M | 196.187 M | 230.104 M | 243.914 M | 342.099 M | 360.290 M | 378.836 M | |
| Accounts Payable | 136.507 M | 178.111 M | 186.429 M | 219.984 M | 234.858 M | 262.530 M | 279.859 M | 298.390 M | |
| Other liabilities | 77.258 M | 76.449 M | 89.420 M | 97.726 M | 114.495 M | 103.279 M | 112.911 M | 100.722 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 178.689 M | 179.330 M | 180.002 M | 180.710 M | 181.377 M | 117.540 M | 117.642 M | 117.746 M | |
| Other liabilities | 77.258 M | 76.449 M | 89.420 M | 97.726 M | 114.495 M | 103.279 M | 112.911 M | 100.722 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 144.036 M | 102.852 M | 92.898 M | 57.015 M | 53.205 M | 73.075 M | 73.727 M | 88.295 M | |
| Common stock | 1.048 B | 1.086 B | 1.141 B | 1.180 B | 1.235 B | 1.303 B | 1.351 B | 1.394 B | |
| Retained earnings | -903.928 M | -983.273 M | -1.048 B | -1.123 B | -1.182 B | -1.230 B | -1.277 B | -1.306 B |